293 related articles for article (PubMed ID: 35015949)
21. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
22. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
[TBL] [Abstract][Full Text] [Related]
23. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
[TBL] [Abstract][Full Text] [Related]
24. Reduction in Length of Stay and Morphine Use for NAS With the "Eat, Sleep, Console" Method.
Blount T; Painter A; Freeman E; Grossman M; Sutton AG
Hosp Pediatr; 2019 Aug; 9(8):615-623. PubMed ID: 31285356
[TBL] [Abstract][Full Text] [Related]
25. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada.
Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R
PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382
[TBL] [Abstract][Full Text] [Related]
26. Neonatal abstinence syndrome.
Kocherlakota P
Pediatrics; 2014 Aug; 134(2):e547-61. PubMed ID: 25070299
[TBL] [Abstract][Full Text] [Related]
27. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
28. Opioid neonatal abstinence syndrome: controversies and implications for practice.
Wolff K; Perez-Montejano R
Curr Drug Abuse Rev; 2014; 7(1):44-58. PubMed ID: 25323126
[TBL] [Abstract][Full Text] [Related]
29. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
30. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
31. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.
Jones HE; Kaltenbach K; Benjamin T; Wachman EM; O'Grady KE
J Addict Med; 2019; 13(2):90-92. PubMed ID: 30334926
[TBL] [Abstract][Full Text] [Related]
32. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
33. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
[TBL] [Abstract][Full Text] [Related]
34. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
[TBL] [Abstract][Full Text] [Related]
35. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
[TBL] [Abstract][Full Text] [Related]
36. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
Ma J; Sahasranaman V; Kirby RS; Boaz T
J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
[TBL] [Abstract][Full Text] [Related]
37. Effects of polysubstance exposure on neonatal outcomes for infants with intrauterine opioid exposure.
McDaniel CE; Test M; Deodhar P; Jennings R; Bove J; Carlin K
J Perinatol; 2020 Oct; 40(10):1489-1496. PubMed ID: 32641774
[TBL] [Abstract][Full Text] [Related]
38. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.
Jones HE; Heil SH; Tuten M; Chisolm MS; Foster JM; O'Grady KE; Kaltenbach K
Drug Alcohol Depend; 2013 Aug; 131(3):271-7. PubMed ID: 23279924
[TBL] [Abstract][Full Text] [Related]
39. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
[TBL] [Abstract][Full Text] [Related]
40. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
